AlphaStar Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

AlphaStar Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,417	Closed	-$753K	–	398
2021 Q4	$753K	Sell	5,417 -94	-2%	-$14.6K	0.06%	213
2021 Q3	$876K	Buy	5,511 +129	+2%	+$21.7K	0.06%	214
2021 Q2	$881K	Sell	5,382 -109	-2%	-$16.8K	0.11%	136
2021 Q1	$827K	Sell	5,491 -106	-2%	-$16.8K	0.13%	116
2020 Q4	$905K	Buy	5,597 +490	+10%	+$70K	0.15%	100
2020 Q3	$702K	Buy	+5,107	New	+$693K	0.14%	100

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AlphaStar Capital Management's IBB Position: Q1 2022 in Review

AlphaStar Capital Management sold out of iShares Biotechnology ETF (IBB) in Q1 2022, closing a stake of 5,417 shares — an estimated $753K sold.

AlphaStar Capital Management first reported a position in IBB in Q3 2020 and held it in 6 quarters. The position peaked at $905K in Q4 2020. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

AlphaStar Capital Management reported no remaining iShares Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
AlphaStar Capital Management sold 5,417 iShares Biotechnology ETF shares in Q1 2022, an estimated $753K.
AlphaStar Capital Management first reported a position in iShares Biotechnology ETF in Q3 2020 and held it in 6 quarters.
AlphaStar Capital Management's iShares Biotechnology ETF position peaked at $905K in Q4 2020.
897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on AlphaStar Capital Management's 13F filing for Q1 2022, filed 28 Apr 2022.